Anavex Life Sciences
AVXL
31 hedge funds and large institutions have $7.63M invested in Anavex Life Sciences in 2015 Q4 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
236% more call options, than puts
Call options by funds: $1.31M | Put options by funds: $389K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.28M |
| 2 |
Jane Street
New York
|
+$993K |
| 3 |
Morgan Stanley
New York
|
+$943K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$868K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$695K |
Top Sellers
AVXL Hedge Fund Activity: Q4 2015 in Review
31 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q4 2015, worth a combined $7.63M.
Buyers outnumbered sellers: 31 funds opened new AVXL positions and 0 closed out — a net gain of 31 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $3.28M.
- 31 institutional investors held Anavex Life Sciences (AVXL) as of Q4 2015, up from 0 in Q3 2015.
- Funds reported $7.63M of Anavex Life Sciences stock for Q4 2015.
- 31 funds opened new Anavex Life Sciences positions in Q4 2015 and 0 closed out, a net change of +31 holders.
- The largest Anavex Life Sciences buyer in Q4 2015 was Vanguard Group, an estimated $3.28M added.
Based on aggregated 13F filings for Q4 2015.